EveryClinicalTrial Competitors

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 38,000 trials and 12 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and one of the largest clinical trial data sets in the industry. More than 1 million registered users across approximately 2,300 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC.

eClinicalWorksis a privately held leader in healthcare IT, providing comprehensive Electronic Health Record (EHR) and Practice Management (PM) solutions used by more than 850,000medical professionalsin more than 20 countries.We developinnovative, customizabletools for documentation, Population Health,PatientEngagement, andRevenueCycleManagement. Through leading-edge technology and putting the needs of clients first, wehelp medical professionals improve the quality of care, reduce costs, and meet regulatory requirements.

For more than 30 years, CureSearch has been a driving force in pediatric cancer research. Recognizing a broken system, growing obstacles, and unmet needs in drug development, we’ve launched an innovative and unique strategy to address the urgent, critical need for new childhood cancer treatments. By supporting CureSearch, you’re funding research that’s on the path to quickly becoming a drug accessible to the children who so desperately need new treatment options, and you’re providing innovative platforms that allow stakeholders to work smarter, faster and more collaboratively. With the expert leadership of our Scientific and Industry Advisory Councils, we identify and fund only the strongest research projects that address areas of unmet need and are most likely to quickly reach patients in the clinic or marketplace. We create connections and community between stakeholders by providing platforms for engagement to allow critical conversations to occur. CureSearch stakeholder meetings such as the annual CureSearch Summit and first-of-its-kind IMPACT Series directly influence and advance pediatric cancer research and drug development. Together, we’re changing the drug development landscape from within and accelerating the development of new treatments for the 42 children diagnosed with cancer each day.